MetaCap

ResMed Inc. (RMD)

NYSE: RMDHealth CareMedical/Dental InstrumentsUSD

235.63-1.25 (-0.53%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

RMD stock chart

Technical analysis

Key statistics

All statistics
Market cap
$33.14B
EPS (TTM)
$10.98
Dividend yield
1.04% ($2.46)
Ex-dividend date
Nov 12, 2026
52-week range
180.27 – 277.67
Day range
234.70 – 242.43
Volume / Avg
1.37M / 1.30M
Beta
—

52-week range

$180.27$277.67

RMD stock today

On Nov 20, RMD ended the session at $235.63, shedding $1.25 (0.53%), versus the S&P 500's 3.70% decline. Shares are 15.1% below their 52-week high of $277.67, set on Feb 10, 2026 and 30.7% above the 52-week low of $180.27, in the middle of the past year's range. RMD is down 2.2% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 6.0%.

At 21.5x trailing earnings, ResMed trades below the peer-group median of 62.1x. Its forward P/E of 17.8x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year. ResMed pays an annual dividend of $2.46 per share, a 1.04% yield at the current price.

Summary generated from market data by MetaCap's automated system. Methodology

About ResMed

Company profile

ResMed Inc. engages in the digital health and cloud-connected medical devices business in the United States and internationally. It operates in two segments, Sleep and Breathing Health, and Residential Care Software.

Industry
Medical/Dental Instruments
CEO
Mr. Michael J. Farrell BE, MBA, SM
Headquarters
San Diego, CA
Employees
11,370
Website
resmed.com

Financial highlights

Full financials

In fiscal 2026, ResMed generated $5.65 billion in revenue, up 9.9% from fiscal 2025, its 17th consecutive year of revenue growth. Net income was $1.52 billion (+8.8% year over year), for a net margin of 26.9% versus a median of 21.8% in the prior 5 years. Gross margin was 61.1% (up from 59.4%) and operating margin 33.4%.

ResMed annual revenue, net income and EPS
Fiscal yearFY 2026FY 2025FY 2024FY 2023FY 2022
Revenue$5.65B$5.15B$4.69B$4.22B$3.58B
Growth+9.85%+9.84%+10.95%+18.02%+11.93%
Net income$1.52B$1.40B$1.02B$897.56M$779.44M
EPS (diluted)$10.43$9.51$6.92$6.09$5.30

Analyst forecast

Forecast

Consensus (20 analysts)

buy

Avg. price target

$264.33+12.18%

  • Strong buy 2
  • Buy 7
  • Hold 10
  • Sell 1
  • Strong sell 0

Target range

Low $210.00High $320.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Oct 29, 2026
EPS actual vs est.
$2.55 vs $2.67
Surprise
-4.49%

Dividends

Dividend history
Annual dividend
$2.46
Last payment
$0.66
Ex-dividend date
Nov 12, 2026

RMD news

All RMD news

ResMed peers

Health Care sector
RMD peer companies
CompanyPrice% ChgMarket capCompare
DXCMDexCom Inc.79.32-1.08%$29.58Bvs RMD
WSTWest Pharmaceutical Services Inc.390.30-1.61%$27.19Bvs RMD
MDLNMedline Inc. Class A37.04-2.11%$48.75Bvs RMD
SOLVSolventum Corporation84.50-1.52%$14.36Bvs RMD
GKOSGlaukos Corporation237.31-0.33%$14.05Bvs RMD
BAXBaxter International Inc.25.390.00%$13.14Bvs RMD
PENPenumbra Inc.319.12-0.28%$12.58Bvs RMD
PODDInsulet Corporation133.17-2.96%$9.24Bvs RMD

Indexes, lists and sector

ResMed stock FAQ

What is ResMed's stock price today?

RMD last traded at $235.63 as of Nov 20, 4:00 PM EST, down 0.53% on the day. Prices are delayed at least 15 minutes.

Does ResMed pay a dividend?

Yes. ResMed pays $2.46 per share annually, a 1.04% yield. The most recent dividend of $0.66 had an ex-dividend date of Nov 12, 2026.

What is RMD's P/E ratio?

RMD trades at a trailing P/E ratio of 21.46 and a forward P/E of 17.82, compared with a median of 62.1 for its closest peers.

Is ResMed in the S&P 500?

Yes. ResMed (RMD) is a constituent of the S&P 500 index.

Who is ResMed's CEO?

Mr. Michael J. Farrell BE, MBA, SM is the chief executive officer of ResMed Inc., which has about 11,370 employees.

Has RMD ever split its stock?

Yes. The most recent RMD stock split was a 2-for-1 split on Aug 31, 2010, one of 4 splits on record.

What is the RMD 52-week high?

The 52-week high for RMD is $277.67 and the 52-week low is $180.27. The stock is currently 15.1% below its high.

Compare RMD